{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T09:46:54Z","timestamp":1791712014897,"version":"4.3.4"},"reference-count":59,"publisher":"Rambam Health Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rambam Maimonides Med J"],"DOI":"10.5041\/rmmj.10166","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T05:23:19Z","timestamp":1414560199000},"page":"e0032","source":"Crossref","is-referenced-by-count":29,"title":["Extracellular Vesicles in Hematological Disorders"],"prefix":"10.5041","volume":"5","author":[{"given":"Anat","family":"Aharon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Rebibo-Sabbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Tzoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2983","published-online":{"date-parts":[[2014,10,29]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.blre.2006.09.001","article-title":"Circulating microparticles: pathophysiology and clinical implications","volume":"21","author":"Piccin","year":"2007","unstructured":"1. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007;21:157-71.","journal-title":"Blood Rev"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ceb.2004.06.003","article-title":"Exosomes: endosomal-derived vesicles shipping extracellular messages","volume":"16","author":"Fevrier","year":"2004","unstructured":"2. Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004;16:415-21.","journal-title":"Curr Opin Cell Biol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"18397","DOI":"10.3402\/jev.v1i0.18397","article-title":"Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation","volume":"1","author":"Bobrie","year":"2012","unstructured":"3. Bobrie A, Colombo M, Krumeich S, et al. Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation. J Extracell Vesicles 2012;1:18397.","journal-title":"J Extracell Vesicles"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1242\/jcs.128868","article-title":"Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles","volume":"126","author":"Colombo","year":"2013","unstructured":"4. Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 2013;126:5553-65.","journal-title":"J Cell Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1091\/mbc.e10-07-0625","article-title":"Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome\/microvesicle proteins","volume":"22","author":"Gan","year":"2011","unstructured":"5. Gan X, Gould SJ. Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome\/microvesicle proteins. Mol Biol Cell 2011;22:817-30.","journal-title":"Mol Biol Cell"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tmrv.2005.08.001","article-title":"Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers","volume":"20","author":"Simak","year":"2006","unstructured":"6. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006;20:1-26.","journal-title":"Transfus Med Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1160\/TH07-02-0082","article-title":"Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism","volume":"98","author":"Essayagh","year":"2007","unstructured":"7. Essayagh S, Xuereb JM, Terrisse AD, et al. Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism. Thromb Haemost 2007; 98:831-7.","journal-title":"Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/77498","article-title":"Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles : a mechanism for cellular human immunodeficiency virus 1 infection","volume":"6","author":"Mack","year":"2000","unstructured":"8. Mack M, Kleinschmidt A, Bruhl H, et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles : a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 2000;6:769-75.","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00262-005-0075-9","article-title":"Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes","volume":"55","author":"Baj-Krzyworzeka","year":"2006","unstructured":"9. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 2006;55:808-18.","journal-title":"Cancer Immunol Immunother"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molmed.2004.02.008","article-title":"Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation","volume":"10","author":"Furie","year":"2004","unstructured":"10. Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 2004;10:171-8.","journal-title":"Trends Mol Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2141.2007.06514.x","article-title":"Plasma microparticles and vascular disorders","volume":"137","author":"SF","year":"2007","unstructured":"11. Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol 2007;137:36-48.","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s00277-002-0494-z","article-title":"Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation","volume":"81","author":"Pihusch","year":"2002","unstructured":"12. Pihusch R, Hohnberg B, Salat C, et al. Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation. Ann Hematol 2002;81:454-61.","journal-title":"Ann Hematol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/sj.leu.2404296","article-title":"Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication","volume":"20","author":"Ratajczak","year":"2006","unstructured":"13. Ratajczak J, Wysoczynski M, Hayek F, et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006;20:1487-95.","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/MCP.0b013e328209413c","article-title":"Risk of venous thromboembolism in lung cancer","volume":"13","author":"ME","year":"2007","unstructured":"14. Tesselaar ME, Osanto S. Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med 2007;13:362-7.","journal-title":"Curr Opin Pulm Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","unstructured":"15. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008;359:938-49.","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1538-7836.2008.02987.x","article-title":"Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation","volume":"6","author":"Davila","year":"2008","unstructured":"16. Davila M, Amirkhosravi A, Coll E, et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 2008;6:1517-24.","journal-title":"J Thromb Haemost"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1182\/blood-2004-03-0935","article-title":"Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation","volume":"104","author":"Chou","year":"2004","unstructured":"17. Chou J, Mackman N, Merrill-Skoloff G, et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004;104:3190-7.","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","article-title":"Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients","volume":"122","author":"JE","year":"2013","unstructured":"18. Geddings JE, Mackman N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 2013;122:1873-80.","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1538-7836.2009.03342.x","article-title":"Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications","volume":"7","author":"Aharon","year":"2009","unstructured":"19. Aharon A, Katzenell S, Tamari T, Brenner B. Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications. J Thromb Haemost 2009;7:1047-50.","journal-title":"J Thromb Haemost"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005;288:H1004-9.","DOI":"10.1152\/ajpheart.00842.2004"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.beha.2008.11.002","article-title":"Microparticles, thrombosis and cancer","volume":"22","author":"Aharon","year":"2009","unstructured":"21. Aharon A, Brenner B. Microparticles, thrombosis and cancer. Best Pract Res Clin Haematol 2009;22:61-9.","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11239-013-1028-3","article-title":"Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease","volume":"38","author":"Kasar","year":"2014","unstructured":"22. Kasar M, Boga C, Yeral M, et al. Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease. J Thromb Thrombolysis 2014;38:167-75.","journal-title":"J Thromb Thrombolysis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1182\/blood-2012-02-413138","article-title":"Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease","volume":"120","author":"Camus","year":"2012","unstructured":"23. Camus SM, Gausseres B, Bonnin P, et al. Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease. Blood 2012; 120:5050-8.","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Nebor D, Bowers A, Connes P, et al. Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia. PLoS One 2014;9:e87243.","DOI":"10.1371\/journal.pone.0087243"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3109\/09537104.2012.749397","article-title":"Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: relation to cardiovascular complications","volume":"24","author":"Tantawy","year":"2013","unstructured":"25. Tantawy AA, Adly AA, Ismail EA, et al. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: relation to cardiovascular complications. Platelets 2013;24:605-14.","journal-title":"Platelets"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3324\/haematol.2012.073619","article-title":"Fetal hemoglobin and hydroxycarbamidemoduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children","volume":"98","author":"Nebor","year":"2013","unstructured":"26. Nebor D, Romana M, Santiago R, et al. Fetal hemoglobin and hydroxycarbamidemoduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children. Haematologica 2013;98:862-7.","journal-title":"Haematologica"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.pcl.2013.08.008","article-title":"Thalassemias","volume":"60","author":"Martin","year":"2013","unstructured":"27. Martin A, Thompson AA. Thalassemias. Pediatr Clin North Am 2013;60:1383-91.","journal-title":"Pediatr Clin North Am"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2141.2006.06449.x","article-title":"Activated platelet-derived microparticles in thalassaemia","volume":"136","author":"Pattanapanyasat","year":"2007","unstructured":"28. Pattanapanyasat K, Gonwong S, Chaichompoo P, et al. Activated platelet-derived microparticles in thalassaemia. Br J Haematol 2007;136:462-71.","journal-title":"Br J Haematol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3324\/haematol.12460","article-title":"Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia","volume":"93","author":"Habib","year":"2008","unstructured":"29. Habib A, Kunzelmann C, Shamseddeen W, et al. Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia. Haematologica 2008;93:941-2.","journal-title":"Haematologica"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3324\/haematol.2013.084533","article-title":"Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase","volume":"99","author":"Ferru","year":"2014","unstructured":"30. Ferru E, Pantaleo A, Carta F, et al. Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase. Haematologica 2014;99:570-8.","journal-title":"Haematologica"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-2141.2010.08505.x","article-title":"Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria","volume":"152","author":"Kozuma","year":"2011","unstructured":"31. Kozuma Y, Sawahata Y, Takei Y, et al. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2011;152:631-9.","journal-title":"Br J Haematol"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Hill A, Kelly RJ, Hillmen P. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 2013;121:4985-96; quiz 5105.","DOI":"10.1182\/blood-2012-09-311381"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1365-2141.2004.04974.x","article-title":"Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria","volume":"125","author":"Simak","year":"2004","unstructured":"33. Simak J, Holada K, Risitano AM, et al. Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2004;125:804-13.","journal-title":"Br J Haematol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1182\/blood.V93.10.3451.410k27_3451_3456","article-title":"Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia","volume":"93","author":"Hugel","year":"1999","unstructured":"34. Hugel B, Socie G, Vu T, et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999;93:3451-6.","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.thromres.2012.04.001","article-title":"Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation","volume":"130","author":"Weitz","year":"2012","unstructured":"35. Weitz IC, Razavi P, Rochanda L, et al. Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation. Thromb Res 2012;130:361-8.","journal-title":"Thromb Res"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Unlu B, Versteeg HH. Effects of tumor-expressed coagulation factors on cancer progression and venous thrombosis: is there a key factor? Thromb Res 2014;133(Suppl 2):S76-84.","DOI":"10.1016\/S0049-3848(14)50013-8"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12307-014-0144-8","article-title":"Small but mighty: microparticles as mediators of tumor progression","volume":"7","author":"Voloshin","year":"2014","unstructured":"37. Voloshin T, Fremder E, Shaked Y. Small but mighty: microparticles as mediators of tumor progression. Cancer Microenviron 2014;7:11-21.","journal-title":"Cancer Microenviron"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-014-0054-8","article-title":"Tissue factor in tumor microenvironment: a systematic review","volume":"7","author":"Han","year":"2014","unstructured":"38. Han X, Guo B, Li Y, Zhu B. Tissue factor in tumor microenvironment: a systematic review. J Hematol Oncol 2014;7:54.","journal-title":"J Hematol Oncol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.phrs.2013.07.009","article-title":"Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways","volume":"76","author":"JF","year":"2013","unstructured":"39. Lu JF, Luk F, Gong J, et al. Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways. Pharmacol Res 2013;76:77-83.","journal-title":"Pharmacol Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1096\/fj.11-186817","article-title":"Microparticle-associated nucleic acids mediate trait dominance in cancer","volume":"26","author":"Jaiswal","year":"2012","unstructured":"40. Jaiswal R, Gong J, Sambasivam S, et al. Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J 2012;26:420-9.","journal-title":"FASEB J"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/cvr\/cvs007","article-title":"Microparticles: major transport vehicles for distinct microRNAs in circulation","volume":"93","author":"Diehl","year":"2012","unstructured":"41. Diehl P, Fricke A, Sander L, et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012;93:633-44.","journal-title":"Cardiovasc Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs-microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher A","year":"2006","unstructured":"42. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69.","journal-title":"Nat Rev Cancer"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"14240","DOI":"10.3390\/ijms140714240","article-title":"Intercellular communication by exosome-derived microRNAs in cancer","volume":"14","author":"BN","year":"2013","unstructured":"43. Hannafon BN, Ding WQ. Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci 2013;14:14240-69.","journal-title":"Int J Mol Sci"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.blre.2013.04.002","article-title":"MicroRNAs in hematological malignancies","volume":"27","author":"Lawrie","year":"2013","unstructured":"44. Lawrie CH. MicroRNAs in hematological malignancies. Blood Rev 2013;27:143-54.","journal-title":"Blood Rev"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1097\/01.tp.0000209218.24916.ba","article-title":"Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients","volume":"81","author":"Pihusch","year":"2006","unstructured":"45. Pihusch V, Rank A, Steber R, et al. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients. Transplantation 2006;81:1405-9.","journal-title":"Transplantation"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.leukres.2011.08.005","article-title":"Elevated Fas\/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis","volume":"36","author":"Wu","year":"2012","unstructured":"46. Wu Q, Chen H, Fang J, et al. Elevated Fas\/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis. Leuk Res 2012; 36:275-80.","journal-title":"Leuk Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/TP.0b013e318221d3e9","article-title":"Microparticles for diagnosis of graft-versus-host disease after allogeneic stem transplantation","volume":"92","author":"Rank","year":"2011","unstructured":"47. Rank A, Nieuwland R, Toth B, et al. Microparticles for diagnosis of graft-versus-host disease after allogeneic stem transplantation. Transplantation 2011;92:244-50.","journal-title":"Transplantation"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1182\/blood-2010-09-305649","article-title":"The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy","volume":"117","author":"Ghosh","year":"2011","unstructured":"48. Ghosh AK, Secreto C, Boysen J, et al. The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy. Blood 2011;117:1928-37.","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1182\/blood-2009-09-242719","article-title":"Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression","volume":"115","author":"Ghosh","year":"2010","unstructured":"49. Ghosh AK, Secreto CR, Knox TR, et al. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood 2010;115:1755-64.","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2014.03.009","article-title":"Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells","volume":"348","author":"Corrado","year":"2014","unstructured":"50. Corrado C, Raimondo S, Saieva L, et al. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells. Cancer Lett 2014;348:71-6.","journal-title":"Cancer Lett"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10456-011-9241-1","article-title":"Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion","volume":"15","author":"Mineo","year":"2012","unstructured":"51. Mineo M, Garfield SH, Taverna S, et al. Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis 2012;15:33-45.","journal-title":"Angiogenesis"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/ijc.26217","article-title":"Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis","volume":"130","author":"Taverna","year":"2012","unstructured":"52. Taverna S, Flugy A, Saieva L, et al. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis. Int J Cancer 2012;130:2033-43.","journal-title":"Int J Cancer"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"53. Cai J, Wu G, Tan X, et al. Transferred BCR\/ABL DNA from K562 extracellular vesicles causes chronic myeloid leukemia in immunodeficient mice. PLoS One 2014;9:e105200.","DOI":"10.1371\/journal.pone.0105200"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s13402-011-0017-9","article-title":"High acute myeloid leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow","volume":"34","author":"Weidenaar","year":"2011","unstructured":"54. Weidenaar AC, ter Elst A, Koopmans-Klein G, et al. High acute myeloid leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow. Cell Oncol (Dordr) 2011;34:289-96.","journal-title":"Cell Oncol (Dordr)"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1182\/blood-2008-08-175745","article-title":"Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival","volume":"113","author":"GH","year":"2009","unstructured":"55. Ku GH, White RH, Chew HK, et al. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 2009;113:3911-17.","journal-title":"Blood"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1538-7836.2010.04133.x","article-title":"Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy","volume":"9","author":"Van Aalderen","year":"2011","unstructured":"56. Van Aalderen MC, Trappenburg MC, Van Schilfgaarde M, et al. Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy. J Thromb Haemost 2011;9:223-6.","journal-title":"J Thromb Haemost"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"57. Wong TW, Kita H, Hanson CA, et al. Induction of malignant plasma cell proliferation by eosinophils. PLoS One 2013;8:e70554.","DOI":"10.1371\/journal.pone.0070554"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"58. Benameur T, Chappard D, Fioleau E, et al. Plasma cells release membrane microparticles in a mouse model of multiple myeloma. Micron 2013;54-55:75-81.","DOI":"10.1016\/j.micron.2013.08.010"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.18632\/oncotarget.2159","article-title":"Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation","volume":"5","author":"Arendt","year":"2014","unstructured":"59. Arendt BK, Walters DK, Wu X, et al. Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation. Oncotarget 2014;5:5686-99.","journal-title":"Oncotarget"}],"container-title":["Rambam Maimonides Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.rmmj.org.il\/userimages\/420\/1\/PublishFiles\/440Article.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T09:03:33Z","timestamp":1791709413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rmmj.org.il\/issues\/23\/Articles\/440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,29]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,10,29]]}},"URL":"https:\/\/doi.org\/10.5041\/rmmj.10166","relation":{},"ISSN":["2076-9172"],"issn-type":[{"value":"2076-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,29]]}}}